List of Boehringer Ingelheim patents

Patents where

Current Assignee

Name

Boehringer Ingelheim

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11407981 Methods for continuously inactivating a virus during manufacture of a protein	Patent 11407981 was granted and assigned to Boehringer Ingelheim on August, 2022 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	11407981	August 9, 2022
‌ US Patent 10435670 Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product	Patent 10435670 was granted and assigned to Boehringer Ingelheim on October, 2019 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	10435670	October 8, 2019
‌ US Patent 11553695 Single or dual technology animal tags and system and method of using the same	Patent 11553695 was granted and assigned to Boehringer Ingelheim on January, 2023 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	11553695	January 17, 2023
‌ US Patent 11285277 Inhaler		Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	11285277	March 29, 2022
‌ US Patent 9089658 Dispensing device, storage device and method for dispensing powder	Patent 9089658 was granted and assigned to Boehringer Ingelheim on July, 2015 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	9089658	July 28, 2015
‌ US Patent 7963955 Container for a medicinal liquid	Patent 7963955 was granted and assigned to Boehringer Ingelheim on June, 2011 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	7963955	June 21, 2011
‌ US Patent 8474447 Inhaler device	Patent 8474447 was granted and assigned to Boehringer Ingelheim on July, 2013 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	8474447	July 2, 2013
‌ US Patent 10287318 Viral vector for the targeted transfer of genes in the brain and spinal cord	Patent 10287318 was granted and assigned to Boehringer Ingelheim on May, 2019 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	10287318	May 14, 2019
‌ US Patent 11549108 Mammalian cells for producing a secreted protein		Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	11549108	January 10, 2023
‌ US Patent 7819342 Atomizer for dispensing liquids for medical purposes	Patent 7819342 was granted and assigned to Boehringer Ingelheim on October, 2010 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	7819342	October 26, 2010
‌ US Patent 9011868 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs	Patent 9011868 was granted and assigned to Boehringer Ingelheim on April, 2015 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	9011868	April 21, 2015
‌ US Patent 9265910 Adapter, inhalation device, and nebulizer	Patent 9265910 was granted and assigned to Boehringer Ingelheim on February, 2016 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	9265910	February 23, 2016
‌ US Patent 11560549 Integration sites in CHO cells	Patent 11560549 was granted and assigned to Boehringer Ingelheim on January, 2023 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	11560549	January 24, 2023
‌ US Patent 11298476 Vibrating blister	Patent 11298476 was granted and assigned to Boehringer Ingelheim on April, 2022 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	11298476	April 12, 2022
‌ US Patent 10131696 PCV2 ORF2 protein variant and virus like particles composed thereof	Patent 10131696 was granted and assigned to Boehringer Ingelheim on November, 2018 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	10131696	November 20, 2018
‌ US Patent 9949997 Pharmaceutical composition, methods for treating and uses thereof	Patent 9949997 was granted and assigned to Boehringer Ingelheim on April, 2018 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	9949997	April 24, 2018
‌ US Patent 7585638 Test system for measuring the interaction of STAT 6 with NCoA-1	Patent 7585638 was granted and assigned to Boehringer Ingelheim on September, 2009 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	7585638	September 8, 2009
‌ US Patent 9505808 PCV2 ORF2 protein variant and virus like particles composed thereof	Patent 9505808 was granted and assigned to Boehringer Ingelheim on November, 2016 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	9505808	November 29, 2016
‌ US Patent 9669087 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs	Patent 9669087 was granted and assigned to Boehringer Ingelheim on June, 2017 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	9669087	June 6, 2017
‌ US Patent 11642476 Nebulizer	Patent 11642476 was granted and assigned to Boehringer Ingelheim on May, 2023 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	11642476	May 9, 2023
‌ US Patent 7989474 Use of Lck inhibitors for treatment of immunologic diseases	Patent 7989474 was granted and assigned to Boehringer Ingelheim on August, 2011 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	7989474	August 2, 2011
‌ US Patent 9011872 PCV2 immunogenic compositions and methods of producing such compositions	Patent 9011872 was granted and assigned to Boehringer Ingelheim on April, 2015 by the United States Patent and Trademark Office.	Boehringer Ingelheim	Boehringer Ingelheim	United States Patent and Trademark Office	9011872	April 21, 2015
‌ US Patent 7968285 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs	Patent 7968285 was granted and assigned to Boehringer Ingelheim on June, 2011 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	7968285	June 28, 2011
‌ US Patent 8950393 Nebulizer	Patent 8950393 was granted and assigned to Boehringer Ingelheim on February, 2015 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	8950393	February 10, 2015
‌ US Patent 7700285 PCV2 immunogenic compositions and methods of producing such compositions	Patent 7700285 was granted and assigned to Boehringer Ingelheim on April, 2010 by the United States Patent and Trademark Office.		Boehringer Ingelheim	United States Patent and Trademark Office	7700285	April 20, 2010

...

Results per page:

1,253 results

0 selected

1,253 results

0 selected